These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25573962)

  • 1. Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer.
    Scully OJ; Yu Y; Salim A; Thike AA; Yip GW; Baeg GH; Tan PH; Matsumoto K; Bay BH
    Exp Biol Med (Maywood); 2015 Jul; 240(7):846-53. PubMed ID: 25573962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological significance of ARID1B in breast invasive ductal carcinoma.
    Shao F; Guo T; Chua PJ; Tang L; Thike AA; Tan PH; Bay BH; Baeg GH
    Histopathology; 2015 Nov; 67(5):709-18. PubMed ID: 25817822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.
    Lwin ZM; Guo C; Salim A; Yip GW; Chew FT; Nan J; Thike AA; Tan PH; Bay BH
    Mod Pathol; 2010 Dec; 23(12):1559-66. PubMed ID: 20834237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactome analysis reveals that C1QBP (complement component 1, q subcomponent binding protein) is associated with cancer cell chemotaxis and metastasis.
    Zhang X; Zhang F; Guo L; Wang Y; Zhang P; Wang R; Zhang N; Chen R
    Mol Cell Proteomics; 2013 Nov; 12(11):3199-209. PubMed ID: 23924515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein.
    Zhong J; Cao RX; Liu JH; Liu YB; Wang J; Liu LP; Chen YJ; Yang J; Zhang QH; Wu Y; Ding WJ; Hong T; Xiao XH; Zu XY; Wen GB
    Oncogene; 2014 Nov; 33(48):5546-58. PubMed ID: 24292672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast.
    Qian L; Gao X; Huang H; Lu S; Cai Y; Hua Y; Liu Y; Zhang J
    Oncotarget; 2017 Mar; 8(13):21444-21453. PubMed ID: 28423522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis.
    Wang Y; Yue D; Xiao M; Qi C; Chen Y; Sun D; Zhang N; Chen R
    J Proteome Res; 2015 Feb; 14(2):804-13. PubMed ID: 25497084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucosyltransferase 8 expression in breast cancer patients: A high throughput tissue microarray analysis.
    Yue L; Han C; Li Z; Li X; Liu D; Liu S; Yu H
    Histol Histopathol; 2016 May; 31(5):547-55. PubMed ID: 26596733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF-1/IGF-1R signaling.
    Shi H; Fang W; Liu M; Fu D
    Int J Cancer; 2017 Oct; 141(7):1389-1401. PubMed ID: 28608366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of GLTSCR2 expression is correlated with breast cancer progression.
    Moon A; Lim SJ; Jo YH; Lee S; Kim JY; Lee J; Park JH
    Pathol Res Pract; 2013 Nov; 209(11):700-4. PubMed ID: 24054033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1QBP Mediates Breast Cancer Cell Proliferation and Growth via Multiple Potential Signalling Pathways.
    Scully OJ; Shyamasundar S; Matsumoto K; Dheen ST; Yip GW; Bay BH
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation.
    Oka K; Suzuki T; Onodera Y; Miki Y; Takagi K; Nagasaki S; Akahira J; Ishida T; Watanabe M; Hirakawa H; Ohuchi N; Sasano H
    Int J Cancer; 2011 Apr; 128(8):1770-82. PubMed ID: 20533549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing the Peroxiredoxin III gene inhibits cell proliferation in breast cancer.
    Chua PJ; Lee EH; Yu Y; Yip GW; Tan PH; Bay BH
    Int J Oncol; 2010 Feb; 36(2):359-64. PubMed ID: 20043069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.
    Lv ZD; Zhang L; Liu XP; Jin LY; Dong Q; Li FN; Wang HB; Kong B
    Int J Clin Exp Pathol; 2015; 8(4):4015-21. PubMed ID: 26097589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of HOXD13 expression in human breast cancer.
    Zhong ZB; Shan M; Qian C; Liu T; Shi QY; Wang J; Liu Y; Liu Y; Huang YX; Pang D
    Int J Clin Exp Pathol; 2015; 8(9):11407-13. PubMed ID: 26617867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of C1QBP gene and its correlation with drug resistance in human resistance choriocarcinoma cell line].
    Shen X; Han B; Shen Y; Yang J; Ren T; Sha G; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):616-20. PubMed ID: 25354864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F-1: a proliferative marker of breast neoplasia.
    Zhang SY; Liu SC; Al-Saleem LF; Holloran D; Babb J; Guo X; Klein-Szanto AJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):395-401. PubMed ID: 10794484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression status of cyclase‑associated protein 2 as a prognostic marker for human breast cancer.
    Xu L; Peng S; Huang Q; Liu Y; Jiang H; Li X; Wang J
    Oncol Rep; 2016 Oct; 36(4):1981-8. PubMed ID: 27573674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance of β -tubulin isotype III gene expression in breast cancer patients.
    He Q; Peng B; Zhuang D; Xiao L; Zheng L; Fan Z; Zhu J; Xu B; Xu C; Zhao J; Wu L; Zhou P; Hou L; Yu F; Zhao G
    Cancer Biomark; 2015; 15(6):823-31. PubMed ID: 26406408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.